Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
This continuing nursing education activity is provided by
Support Statement: This activity is supported by educational grants from Genentech, Inc., Genzyme, A Sanofi Company, and Novartis Pharmaceuticals Corporation.
There is no non-commercial support for this activity.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Target Audience: The intended audience for this activity is neurologists, neurology nurses, and other health care professionals involved in the treatment of patients with multiple sclerosis.
Purpose/Learning Objectives:
Upon successful completion of this activity, participants should be better able to evaluate the safety, efficacy, and appropriate use of disease-modifying therapy for the treatment of multiple sclerosis.
Activity Chair:
Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director
Multiple Sclerosis Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY
Steering Committee:
Guy J. Buckle, MD, MPH
Director of Neuroimaging Research
Andrew C. Carlos MS Institute at Shepherd Center
Atlanta, GA
Bruce A. Cohen, MD
Professor of Neurology
Northwestern University
Feinberg School of Medicine
Director
Northwestern Comprehensive Multiple Sclerosis Program
Chicago, IL
Clyde E. Markowitz, MD
Associate Professor of Neurology
Director, Multiple Sclerosis Center
Hospital of the University of Pennsylvania
Perelman School of Medicine
Philadelphia, PA
Peer Reviewer:
Brian M. Shepler, PharmD
Nurse Planners:
Barbara A. Niedz, PhD, RN, CPHQ
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center’s Standards for Commercial Support, all CME/CNE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, authors, and reviewers involved in the development of CME/CNE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CNE activity content over which the individual has control. Relationship information appears below.
Activity Chair and Steering Committee report the following relationship(s):
Patricia K. Coyle, MD, FAAN, FANA
Consulting Fee: Accordant, Bayer, Biogen, Genentech/Roche, Mallincrkrodt, Novartis, Sanofi-Genzyme, Serono
Contracted Research: Actelion, Genentech/Roche, Novartis, Opexa
Guy J. Buckle, MD, MPH
Consulting Fee: Bayer, Biogen, EMD-Serono, Genentech, Genzyme-Sanofi, Mallinckrodt, Novartis, Teva
Speakers Bureau: Biogen, EMD-Serono, Genentech, Genzyme-Sanofi, Mallinckrodt, Novartis, Teva
Contracted Research: Biogen (PI)
Bruce A. Cohen, MD
Consulting Fee: Biogen-Idec, EMD-Serono, Genentech, Genzyme, Novartis
Clyde E. Markowitz, MD
Consulting Fee: Bayer, Biogen, EMD-Serono, Genentech, Genzyme, Novartis, Opexa, Roche, Sanofi, Teva
Peer Reviewer reports the following relationship(s):
Brian M. Shepler, PharmD
No relevant financial relationships to disclose.
Nurse Planners report the following relationship(s):
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Consulting Fee: Acorda, Biogen, EMD Serono, Genzyme, Novartis, Teva
Speakers Bureau: Acorda, Bayer, EMD Serono, Genentech, Genzyme, Mallinckrodt, Novartis, Teva
Purdue University and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Purdue University and Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Accreditation:
Purdue University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Credit Designation:
Purdue University designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education will provide 0.50 contact hours for nurses.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 0.5 hours credit for completing this program.
This activity is approved for 1 year from the date of original release, December 16, 2016 to December 15, 2017.
How to Participate in this Activity and Obtain CME/CNE Credit:
To participate in this CME/CNE activity, you must read the objective, answer the pretest questions, read the article, and complete the CME/CNE posttest and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Purdue University will issue an AMA PRA Category 1 Credit(s)™ Certificate or Vindico Medical Education will issue a Learner-Paced Contact Hours Certificate.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME/CNE Questions?
Contact us at cme@vindicoCME.com